Additionally, RANKL production was suppressed by peficitinib, but not by etanercept, which is in line with the conclusions on the pathophysiology of the RA-related osteoporosis delineated from the studies mentioned before. The gene discussed is TNFSF11; the disease is rheumatoid arthritis.